Publication: In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported
| dc.contributor.author | Tauangtham Anekpuritanang | en_US |
| dc.contributor.author | Matthew M. Klairmont | en_US |
| dc.contributor.author | Joel Gradowski | en_US |
| dc.contributor.author | Kohei Hagiwara | en_US |
| dc.contributor.author | Nathanael G. Bailey | en_US |
| dc.contributor.author | Pranil Chandra | en_US |
| dc.contributor.author | Yiwei Liu | en_US |
| dc.contributor.author | Heather L. Mulder | en_US |
| dc.contributor.author | John Easton | en_US |
| dc.contributor.author | Jinghui Zhang | en_US |
| dc.contributor.author | Michael G. Martin | en_US |
| dc.contributor.author | Anna B. Owczarczyk | en_US |
| dc.contributor.author | Jennifer B. Dunlap | en_US |
| dc.contributor.author | Guang Fan | en_US |
| dc.contributor.author | Richard D. Press | en_US |
| dc.contributor.author | Philipp W. Raess | en_US |
| dc.contributor.other | Siriraj Hospital | en_US |
| dc.contributor.other | University of Michigan Medical School | en_US |
| dc.contributor.other | OHSU School of Medicine | en_US |
| dc.contributor.other | St. Jude Children's Research Hospital | en_US |
| dc.contributor.other | Oregon Health & Science University | en_US |
| dc.contributor.other | University of Tennessee Health Science Center | en_US |
| dc.contributor.other | University of Pittsburgh School of Medicine | en_US |
| dc.contributor.other | PathGroup | en_US |
| dc.date.accessioned | 2022-08-04T08:58:03Z | |
| dc.date.available | 2022-08-04T08:58:03Z | |
| dc.date.issued | 2021-12-14 | en_US |
| dc.identifier.citation | Blood Advances. Vol.5, (2021), 5057-5059 | en_US |
| dc.identifier.doi | 10.1182/bloodadvances.2021004983 | en_US |
| dc.identifier.issn | 24739537 | en_US |
| dc.identifier.issn | 24739529 | en_US |
| dc.identifier.other | 2-s2.0-85121731933 | en_US |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/77401 | |
| dc.rights | Mahidol University | en_US |
| dc.rights.holder | SCOPUS | en_US |
| dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121731933&origin=inward | en_US |
| dc.subject | Medicine | en_US |
| dc.title | In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported | en_US |
| dc.type | Letter | en_US |
| dspace.entity.type | Publication | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121731933&origin=inward | en_US |